Showing 2021-2030 of 9078 results for "".
SCALE 2024: Dr. Linda Stein Gold on Benzyne Release From Benzyl Peroxide
https://practicaldermatology.com/conferences/scale-2024/scale-2024-dr-linda-stein-gold-benzyne-release-from-benzyl-peroxide/26373/Linda Stein Gold, MD, discusses the new information on benzyl peroxide and its implications at Music City SCALE.ISDPA: Dr. Bhatia on JAK Inhibitors
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-jak-inhibitors/27064/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks about his presentation on JAK inhibitors at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Advocating for HS Patients
https://practicaldermatology.com/series/c-suite-chats/advocating-for-hs-patients/54617/Camille Lee, Head of US Immunology at UCB, discusses how her company has worked to elevate the hidradenitis suppurativa (HS) community and what it means to be patient-centric.The Benefits of Balneotherapy for Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/the-benefits-of-balneotherapy-for-atopic-dermatitis/39776/Practical Dermatology editorial board member Peter Lio, MD, and Karan Lal, DO, MS, FAAD, discuss the use of balneotherapy as an adjunctive treatment for dermatologic diseases, including an International Journal of Biometeorology article titled, “Balneotherapy using thermal mineral water baths and deSequencing Therapies for Long-Term Control of Atopic Dermatitis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/sequencing-therapies-for-long-term-control-of-atopic-dermatitis/48786/Christopher Bunick, MD, FAAD, talks about the six effective and safe advanced systemic therapies for atopic dermatitis and how to prescribe them for patients as early as possible by understanding the guidelines and the labels.DWTV Extra: Remembering Dr. Robert Sidbury
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-remembering-dr-robert-sidbury/36520/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD; Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD; and Board Member Peter A. Lio, MD, FAAD, reflect on the life and career of their colleague Robert Sidbury, MD, MPH, who passed away suddenly at the age of 61.Long-Term Bimzelx Data Presented
https://practicaldermatology.com/series/dermwire-tv/long-term-bimzelx-data-presented/35563/In this week's DermwireTV, new long-term data is presented for Bimzelx (bimekizumab-bkzx) for two indications; an analysis examines the correlation between proximity to tanning facilities and melanoma incidence; and in our C-Suite Chats feature, we hear from the Founder and CEO of Joya Health.Step Therapy Reform Advocates Seek to Spread Awareness of Proposed Law
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/step-therapy-reform-advocates-seek-to-spread-awareness-of-proposed-law/33160/The Safe Step Act would stop insurance companies under certain circumstances from requiring alternative medications before covering biologics.What's New in Atopic Dermatitis?
https://practicaldermatology.com/programs/practical-dermatology/whats-new-in-atopic-dermatitis/33014/Emma Guttman, MD, PhD, professor and chair of dermatology at Mount Sinai, talks about the latest developments in treatments and therapies for atopic dermatitis.Analysis Evaluates Risks of Cardiovascular Events Among Biologics for Psoriatic Diseases
https://practicaldermatology.com/series/dermwire-tv/analysis-evaluates-risks-of-cardiovascular-events-among-biologics-for-psoriatic-diseases/32412/In this week's DermwireTV, a new analysis evaluates the risks of major adverse cardiovascular events among patients treated with biologics for psoriatic diseases; a phase 3 clinical trial examines the use of nemolizumab in adults with prurigo nodularis; and the president of Journey Medical discusses